Remix.run Logo
Certain Bulk Drug Substances Use in Compounding Present Significant Safety Risks(fda.gov)
4 points by randycupertino 11 hours ago | 1 comments
randycupertino 11 hours ago | parent [-]

Timely press release given the current popularity of the cheaper options of compounding GLP-1s and this admin's recent cozying up with Novo Nordisk and Eli Lilly.